Literature DB >> 17763578

Prevalence and risk factors of peripheral arterial disease in diabetic patients over 50 years old in China.

Heng Guan1, Yong-Jun Li, Zhang-Rong Xu, Guang-Wei Li, Xiao-Hui Guo, Zhi-Min Liu, Da-Jin Zou, Hui-Li Xing, Wei Liu, Zheng-Yan Sheng, Hao-Ming Tian, Da-Long Zhu, De-Min Yu, Wei-Te Zhuang, Lu-Lu Chen, Jian-Ping Weng.   

Abstract

OBJECTIVE: To investigate the prevalence of peripheral arterial disease (PAD) in China type 2 diabetic patients and to demonstrate the relationships between putative risk factors and PAD.
METHODS: In total 1,397 type 2 diabetic patients aged 50 years and older were enrolled and determined ankle-brachial index (ABI) and brachial-ankle pulse wave velocity (baPWV) in 15 Class III Grade A hospitals in 7 major cities of China.
RESULTS: Mean patient age was 63.7 +/- 8.2 years and mean duration of diabetes mellitus was 9.39 +/- 7.4 years. Two hundreds and seventy-two (19.47%) patients were diagnosed as PAD by ABI < 0.9, 122 (18.37%) in male and 150 (20.46%) in female. PAD patients had a significantly longer duration of diabetes mellitus, higher hemoglobin A1c, and a significantly lower mean body mass index than non-PAD ones. Aging, smoking, and systolic blood pressure were found to be positively related with the prevalence of PAD. In terms of lipid profiles, no variable was found to relate with PAD. Notably, baPWV showed as the same significant guiding index for PAD, almost matched with ABI.
CONCLUSIONS: PAD is a common complication in China type 2 diabetic patients. Therefore, PAD screening and treatment should be emphasized for diabetic patients with high risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 17763578

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  9 in total

1.  Nomogram Model for Predicting the Risk of Multidrug-Resistant Bacteria Infection in Diabetic Foot Patients.

Authors:  Yi-Ni Ma; Li-Xiang Zhang; Yuan-Yuan Hu; Tian-Lu Shi
Journal:  Infect Drug Resist       Date:  2021-02-18       Impact factor: 4.003

Review 2.  Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot.

Authors:  Qinan Wu; Bing Chen; Ziwen Liang
Journal:  Stem Cells Int       Date:  2016-10-27       Impact factor: 5.443

3.  Factors associated with lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus: A case-control study.

Authors:  Qingge Gao; Binbin He; Chaoyu Zhu; Yuanyuan Xiao; Li Wei; Weiping Jia
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

4.  The Validity and Reliability between Automated Oscillometric Measurement of Ankle-Brachial Index and Standard Measurement by Eco-Doppler in Diabetic Patients with or without Diabetic Foot.

Authors:  Jing Ma; Min Liu; Dawei Chen; Chun Wang; Guanjian Liu; Xingwu Ran
Journal:  Int J Endocrinol       Date:  2017-05-09       Impact factor: 3.257

5.  Correlation Between ApoE Gene Polymorphism and LEAD in Patients with T2DM That are of Han Nationality in Northern China.

Authors:  Xiao Liu; Huimin Zhou; Xinyi Li; Rui Zhang; Chenxu Zhao; Yaru Zhou; Shunjiang Xu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

6.  Secular trends in the epidemiologic patterns of peripheral artery disease and risk factors in China from 1990 to 2019: Findings from the global burden of disease study 2019.

Authors:  Wei Gong; Shuhan Shen; Xiaojing Shi
Journal:  Front Cardiovasc Med       Date:  2022-09-20

7.  Iron Metabolism Markers and Lower Extremity Arterial Disease in People with Type 2 Diabetes.

Authors:  Hua Jin; Peihong Chen; Shan Zhang; Ping Wu; Xuemei Yu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-11       Impact factor: 3.249

8.  The protective effect of Bcl-xl overexpression against oxidative stress-induced vascular endothelial cell injury and the role of the Akt/eNOS pathway.

Authors:  Leng Ni; Tianjia Li; Bao Liu; Xitao Song; Genhuan Yang; Linfang Wang; Shiying Miao; Changwei Liu
Journal:  Int J Mol Sci       Date:  2013-11-08       Impact factor: 5.923

9.  Standards of care for type 2 diabetes in China.

Authors:  Jianping Weng; Linong Ji; Weiping Jia; Juming Lu; Zhiguang Zhou; Dajin Zou; Dalong Zhu; Liming Chen; Li Chen; Lixin Guo; Xiaohui Guo; Qiuhe Ji; Qifu Li; Xiaoying Li; Jing Liu; Xingwu Ran; Zhongyan Shan; Lixin Shi; Guangyao Song; Liyong Yang; Yuzhi Yang; Wenying Yang
Journal:  Diabetes Metab Res Rev       Date:  2016-07       Impact factor: 4.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.